51. 全身性強皮症 ［臨床試験数：466，薬物数：536（DrugBank：142），標的遺伝子数：110，標的パスウェイ数：210］
Searched query = "Scleroderma", "Systemic sclerosis", "SSc", "dcSSc", "lcSSc"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||EUCTR2019-003906-28-FR||24/02/2020||18/11/2019||Adipose tissu derived-stem cells injections from patients with sclerodermia to treat thier refractory digital ulcers.||Subcutaneous injections of autologous cultured adipose-derived stroma/stem cells to heal refractory ischemic digital ulcers in patients with scleroderma : a phase II study - ADUSE||Patients with systemic sclerosis presenting digital ulcer : - located beyond the proximal interphalangeal joint, on finger surface (included periungueal ulcers), - of ischemic origin according to the physician, - not over subcutaneous calcifications or bone relief, - active DU - refractory after 10±2 weeks of standard of care (that is either still active or new occurrence despite standard of care);Therapeutic area: Diseases [C] - Immune System Diseases [C20]||CHU de Toulouse||NULL||Authorised-recruitment may be ongoing or finished|| Female: yes|
|32||Human pharmacology (Phase 1): no Therapeut1c exploratory (Phase 2): yes Therapeut1c conf1rmatory - (Phase 3): no Therapeut1c use (Phase 4): no||France|
|2||NCT00278525||September 2005||15/1/2006||Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma||Trial of High Dose Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG) With Hematopoietic Stem Cell Support in Patients With Systemic Scleroderma: A Randomized Trial||SYSTEMIC SCLERODERMA||Drug: standard of care;Procedure: stem cell transplantation||Northwestern University||NULL||Completed||N/A||60 Years||All||19||Phase 2||United States|